Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi
Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi
Big Pharma's now got a one-person play called...Big Pharma...! in which writer-director-actor Jennifer Berry apparently skewers said industry. How many plays get reviewed by both the LA Weekly and PLOS Biology? Read on...
Despite 15 years as a cancer doctor and researcher, I struggle several times each week to endure the hardest part of my job – walking into a patient's room to helplessly watch as cancer steals away their life and torments them and their loved ones...we
Despite 15 years as a cancer doctor and researcher, I struggle several times each week to endure the hardest part of my job – walking into a patient's room to helplessly watch as cancer steals away their life and torments them and their loved ones...we
Die Entwicklung der pharmakologischen Behandlung Schizophrener, überprüft anhand repräsentativer Stichproben aus den Jahren 1985, 1989, 1993 und 1997. Ergebnisse aus einem psychiatrischen Großkrankenhaus
The impact of digital influencers on healthcare is likely to be immense with both illuminating and insidious aspects. Good digital influencers will continue to redefine and positively impact the healthcare industry.
Together, they paint a picture of an institutional set up for public-private partnerships that enshrines ‘privileges and advantages’ for the private sector and ‘duties and obligations’ for the public sector, with worrying implications for the sidelining of the public interest in a wide range of subjects: from neglecting pandemic preparedness, to fuelling deforestation and climate change.
M. JC. Journal of Communication In Healthcare, 4 (1):
27-37(2011-04-01T00:00:00)a must for those working in both pharma and medical device environment. It will help you to face coming drastic adjustments; do not hesitate to liaise with me at jc.hansen@stratadviser.com.